SynthesisFrontiers in oncology2026

Oral selective estrogen receptor degraders in ER+/HER2- breast cancer: a systematic review with pooled analysis of metastatic randomized trials and narrative synthesis of adjuvant evidence.

Bing Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.